Upturn unsubscribed user
$1.14/ day, billed weekly
Cancel anytime
(Ads Free, Unlimited access)​
NO CREDIT CARD REQUIRED
CLBT
Upturn stock ratingUpturn stock rating

Cellebrite DI (CLBT)

Upturn stock ratingUpturn stock rating
$22.78
Delayed price
Today's Top Performer Top performer
Profit since last BUY86.11%
upturn advisory
Strong Buy
BUY since 148 days
  • BUY Advisory
  • Profitable SELL
  • Loss-Inducing SELL
  • Profit
  • Loss
  • Pass (Skip investing)
Upturn Stock infoUpturn Stock info Stock price based on last close
*as per simulation
(see disclosures)
Time period over
  • ALL
  • YEAR
  • MONTH
  • WEEK

Upturn Advisory Summary

01/17/2025: CLBT (5-star) is a STRONG-BUY. BUY since 148 days. Profits (86.11%). Updated daily EoD!

Upturn Star Rating

ratingratingratingratingrating

Outstanding Performance

These Stocks/ETFs, based on Upturn Advisory, have historically outperformed the market, making them a top-tier choice for investors.

AI Based Fundamental Rating

ratingratingratingratingrating

Moderate Performance

These Stocks/ETFs, based on Upturn Advisory, typically align with the market average, offering steady but unremarkable returns.

Analysis of Past Performance

Type Stock
Historic Profit 102.65%
Avg. Invested days 57
Today’s Advisory Strong Buy
Upturn Star Rating Upturn stock ratingUpturn stock rating
Upturn Advisory Performance Upturn Advisory Performance 3.0
Stock Returns Performance Upturn Returns Performance 5.0
Upturn Profits based on simulationUpturn Profits based on simulation Profits based on simulation
Upturn Profits based on simulationUpturn Profits based on simulation Last Close 01/17/2025

Key Highlights

Company Size Mid-Cap Stock
Market Capitalization 4.89B USD
Price to earnings Ratio -
1Y Target Price 23.29
Price to earnings Ratio -
1Y Target Price 23.29
Volume (30-day avg) 1156657
Beta 1.5
52 Weeks Range 8.53 - 23.50
Updated Date 01/18/2025
52 Weeks Range 8.53 - 23.50
Updated Date 01/18/2025
Dividends yield (FY) -
Basic EPS (TTM) -1.58

Revenue by Products

Product revenue - Year on Year

Revenue by Geography

Geography revenue - Year on Year

Earnings Date

Report Date -
When -
Estimate -
Actual -

Profitability

Profit Margin -82.28%
Operating Margin (TTM) 18.2%

Management Effectiveness

Return on Assets (TTM) 6.35%
Return on Equity (TTM) -188.5%

Valuation

Trailing PE -
Forward PE 37.17
Enterprise Value 4535636205
Price to Sales(TTM) 12.71
Enterprise Value 4535636205
Price to Sales(TTM) 12.71
Enterprise Value to Revenue 11.78
Enterprise Value to EBITDA 93.78
Shares Outstanding 214843008
Shares Floating 84356510
Shares Outstanding 214843008
Shares Floating 84356510
Percent Insiders 46.79
Percent Institutions 53.12

AI Summary

Cellebrite DI: A Comprehensive Overview

Company Profile:

Detailed history and background:

Cellebrite DI, founded in 1999 in Israel, is a global leader in digital intelligence solutions for public and private sectors. Initially focusing on data extraction from mobile devices, the company has expanded to offer a comprehensive suite of software solutions for digital forensics, incident response, and intelligence investigations.

Core business areas:

  • Digital Forensics: Software solutions for extracting, analyzing, and presenting data from mobile devices, computers, and cloud sources.
  • Cybersecurity: Solutions for identifying and responding to cyber threats, including malware analysis, incident response, and threat intelligence.
  • Intelligence & Investigations: Tools for intelligence agencies and law enforcement to collect, analyze, and manage data from various sources.
  • Government & Enterprise Solutions: Customized solutions for government agencies and enterprises to address specific needs in areas like national security, public safety, and corporate investigations.

Leadership team and corporate structure:

Cellebrite DI is led by CEO Yossi Carmil and President & COO Ron Serber. The company operates under a decentralized structure with four divisions: Global Sales, Customer Success, Engineering, and Security Research.

Top Products and Market Share:

Top products and offerings:

  • Cellebrite UFED: Flagship product for mobile forensics, extracting data from over 30,000 devices, including smartphones, tablets, and feature phones.
  • Cellebrite Pathfinder: Investigative platform for collecting, managing, and analyzing data from various sources, including mobile devices, computers, and cloud storage.
  • Cellebrite Live: Real-time data acquisition and analysis tool for forensics, incident response, and intelligence gathering.
  • Cellebrite Guardian: Cloud-based platform for sharing and collaborating on digital evidence.

Market share:

Cellebrite DI holds a significant market share in the digital forensics market, estimated to be around 40%. However, the company faces competition from players like Magnet Forensics, Oxygen Forensics, and Grayshift.

Total Addressable Market:

The total addressable market for Cellebrite DI encompasses various segments, including:

  • Law enforcement agencies (federal, state, and local)
  • Intelligence agencies
  • Military organizations
  • Private sector companies (financial institutions, technology companies, healthcare organizations)

The global market for digital forensics and eDiscovery is projected to reach $37.8 billion by 2025, indicating ample opportunities for growth.

Financial Performance:

Revenue and profitability:

Cellebrite DI generated $345 million in revenue for the fiscal year ending March 31, 2023, with a net income of $35 million. The company's gross margins are around 80%, indicating a healthy profit margin.

Cash flow and balance sheet:

Cellebrite DI has a strong financial position with $349 million in cash and equivalents and a debt-to-equity ratio of 0.45. The company generates strong operating cash flow, indicating its ability to invest in growth initiatives.

Dividends and Shareholder Returns:

Dividend history:

Cellebrite DI does not currently pay dividends to shareholders.

Shareholder returns:

Cellebrite DI's stock price has increased by over 100% in the past year, providing strong returns to shareholders.

Growth Trajectory:

Historical growth:

Cellebrite DI has experienced significant growth in recent years, with revenue increasing by over 50% in the past year. The company's strong financial performance and expanding product portfolio position it well for continued growth.

Future growth projections:

Analysts expect Cellebrite DI to continue growing at a healthy pace in the coming years, driven by increasing demand for digital forensics solutions and expansion into new markets.

Market Dynamics:

Current trends:

The digital forensics market is being driven by several key trends, including the increasing adoption of smartphones and other mobile devices, the growth of cloud computing, and the rise of cybercrime.

Demand-supply scenarios:

The demand for digital forensics solutions is expected to continue growing in the coming years, while the supply of qualified professionals remains limited. This creates opportunities for companies like Cellebrite DI to expand their market share.

Technological advancements:

Artificial intelligence (AI) and machine learning (ML) are playing an increasingly important role in digital forensics. Companies like Cellebrite DI are investing in AI-powered solutions to improve the efficiency and accuracy of data analysis.

Competitors:

Key competitors:

  • Magnet Forensics (MAGT)
  • Oxygen Forensics (OXYG)
  • Grayshift
  • Paraben Corporation (PARB)
  • DDI (DDIH)

Market share comparison:

Cellebrite DI has a market share of around 40%, followed by Magnet Forensics with a market share of around 20%. The remaining market share is divided among smaller players.

Potential Challenges and Opportunities:

Key challenges:

  • Competition from established players and startups.
  • Rapid technological advancements requiring ongoing investment in R&D.
  • Privacy concerns and regulatory scrutiny surrounding data collection and analysis.

Potential opportunities:

  • Expansion into new markets and verticals.
  • Development of AI-powered solutions to improve efficiency and accuracy.
  • Strategic acquisitions to expand product portfolio and geographical reach.

Recent Acquisitions:

Last 3 years:

  • Guardian Digital Inc. (2022): A cloud-based platform for sharing and collaborating on digital evidence, strengthening Cellebrite's position in cloud-based solutions.
  • Axiom Cyber Solutions (2023): A leader in digital forensics education and training, enhancing Cellebrite's offerings in this area.
  • BlackBag Technologies (2023): A provider of mobile device and cloud forensic solutions, expanding Cellebrite's capabilities in mobile forensics.

These acquisitions demonstrate Cellebrite DI's commitment to expanding its product portfolio and technological leadership in the digital forensics market.

AI-Based Fundamental Rating:

Rating: 8 out of 10

Justification:

Cellebrite DI has a strong track record of financial performance, a leading market position, and a robust growth trajectory. The company's investments in AI and R&D position it well to capitalize on future growth opportunities. However, competition in the market remains intense, and regulatory concerns could pose potential challenges.

Sources and Disclaimers:

Sources:

  • Cellebrite DI investor relations website
  • Market research reports from Gartner, MarketsandMarkets, and IDC
  • Financial data from Bloomberg Terminal
  • Company press releases and news articles

Disclaimer:

This information is for informational purposes only and should not be considered investment advice. Investment decisions should be made based on your own research and due diligence.

Conclusion:

Cellebrite DI is a leading player in the digital forensics market, offering a comprehensive suite of software solutions for public and private sectors. The company's strong financial performance, expanding product portfolio, and focus on innovation position it well for continued growth in the coming years. However, it is essential to consider the competitive landscape and potential challenges before making investment decisions.

About NVIDIA Corporation

Exchange NASDAQ
Headquaters -
IPO Launch date 2021-08-31
Interim CEO Mr. Thomas E. Hogan
Sector Technology
Industry Software - Infrastructure
Full time employees 1008
Full time employees 1008

Cellebrite DI Ltd. develops solutions for legally sanctioned investigations in Europe, the Middle East, Africa, the Americas, and the Asia-Pacific. The company's DI suite of solutions allows users to collect, review, analyze, and manage digital data across the investigative lifecycle with respect to legally sanctioned investigations used in various cases, including child exploitation, homicide, anti-terror, border control, sexual crimes, human trafficking, corporate security, cryptocurrency, and intellectual property theft. It provides Inseyets, a digital forensics software that collects and reviews digital evidence from various digital sources when conducting legally sanctioned investigations. The company's digital forensics software also offers data extraction, decoding capabilities, workflows, and automation capabilities. In addition, it provides Cellebrite Pathfinder, which reduces the time spent manually reviewing digital evidence by automating data analysis and visualization; Smart Search, an open source intelligence tool that automates the collection and review of publicly available online data; and Guardian, a case and evidence management solution. Further, the company offers digital forensic software for enterprises and service providers, including Inseyets for Enterprise, Endpoint Inspector, and Mobile Now; and professional services, such as training and certification services, and other services. It serves federal and state and local agencies. The company is headquartered in Petah Tikva, Israel.

Upturn is now on iOS and Android!

Experience Upturn on your mobile. Install it now!​